4 completed. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
Follow AZD4017: new trials by email Literature Review of AZD4017 trials Research Report on AZD4017
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate Methods That Assess the Effect of AZD4017 in Adipose Tissue AZD4017, Placebo - Obesity | Phase 1 | Completed | AstraZeneca | 15 | 2010-03-01 | 2010-12-10 |
| Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4017 After Repeated Ascending Oral Doses AZD4017, Placebo - Diabetes Mellitus Type 2 | Phase 1 | Completed | AstraZeneca | 107 | 2009-02-01 | 2009-09-30 |
| Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017. AZD4017, Placebo - Healthy | Phase 1 | Completed | AstraZeneca | 56 | 2008-12-01 | 2009-07-02 |
| Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017 AZD4017, Placebo - Healthy | Phase 1 | Completed | AstraZeneca | 40 | 2008-11-01 | 2009-06-16 |
Diabetes Mellitus, Type 2 (1) · Obesity (1)
AstraZeneca (4)
Sweden (3) · Japan (1)
Marianne Hartford, MD PhD (2) · Per-Anders Jansson, Ass Prof, MD, PhD (1) · Shunji Matsuki (1)